PharmaZell and Novasep come together to form a formidable API and CDMO platform
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
They enter into exclusive negotiations in a new drive to create a technology-driven leader for complex small molecules and ADCs of global scale
This partnership strengthens LMS as a leading CDMO supplier of peptide materials for both innovator and generic markets
This collaboration sets the stage for WuXi Biologics’ first integrated CRDMO center in the region
Ascelis Center of Excellence for Peptide Development and Characterization will drive the development of cosmetic, therapeutic, and pharmaceutical peptides
Nitrosamines have prompted evolving global guidelines that demand rigorous industry oversight
Grangemouth serves as PPS’s dedicated antibody-drug conjugate development and manufacturing hub
Consolidated revenue from operations stood at Rs. 111.05 crore
The successful refinancing and enhancement of the syndicated credit facilities provides access to an additional CHF 40 million
Subscribe To Our Newsletter & Stay Updated